Key result
Early Vascular Aging (EVA) syndrome is linked to hypertension and non-hemodynamic factors, presenting potential new drug targets for preventive therapy against arterial stiffness.
Design
Review
Authors
Loading...
EVA may warrant attention as a preventive target; leaves open whether stiffness-focused interventions improve outcomes beyond BP control.
Early Vascular Aging (EVA) is characterized by arterial stiffness and is influenced by both hemodynamic factors like hypertension and non-hemodynamic factors, presenting a potential target for preventive therapies.
Peter M. Nilsson (2020) conducted a review in Hypertension and Early Vascular Aging. Early Vascular Aging was evaluated. Early Vascular Aging (EVA) syndrome is linked to hypertension and non-hemodynamic factors, presenting potential new drug targets for preventive therapy against arterial stiffness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: